Fibromyalgia syndrome - Novel therapeutic targets

Jacob N. Ablin, Dan Buskila

    Research output: Contribution to journalReview articlepeer-review

    17 Scopus citations

    Abstract

    Fibromyalgia is a syndrome characterized by the presence of chronic widespread pain, representing sensitization of the central nervous system. The pthophysiology of fibromyalgia is a complex and remains in evolution, encompassing diverse issues such as disturbed patterns of sleep, alter processing and decreased conditioned pain modulation at the spinal level, as well as increased connectivity between various pain - processing areas of the brain. This evolution is continuously uncovering potential novel therapeutic targets. Treatment of fibromyalgia is a multi - faceted endeavor, inevitably combining pharmacological as well as non - pharmacological approaches. 2δ ligands and selective nor-epinephrine - serotonin reuptake inhibitors are the current mainstays of pharmacological treatment. Novel re-uptake inhibitors targeting both nor -epinephrine and dopamine are potential additions to this armamentarium as are substance P antagonists, Opiod antagonism is another intriguing possibility. Canabinoid agonists hold promise in the treatment of fibromyalgia although current evidence is incomplete. Sodium Oxybate is a unique sleep - promoting medication while drugs those promot arousals such as modafilnil are also under investigation. In the current review, current and emerging therapeutic options for the syndrome of fibromyalgia are covered.

    Original languageEnglish
    Pages (from-to)335-340
    Number of pages6
    JournalMaturitas
    Volume75
    Issue number4
    DOIs
    StatePublished - 1 Aug 2013

    Keywords

    • Central pain
    • Fibromyalgia
    • Treatment

    ASJC Scopus subject areas

    • Biochemistry, Genetics and Molecular Biology (all)
    • Obstetrics and Gynecology

    Fingerprint

    Dive into the research topics of 'Fibromyalgia syndrome - Novel therapeutic targets'. Together they form a unique fingerprint.

    Cite this